<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate <z:chebi fb="27" ids="27300">vitamin D</z:chebi> as a predictor of glycaemic regulation in type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> patients </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: In observational study 171 type 2 diabetic patients who are followed for median (range) of 10.15 (3-18) years </plain></SENT>
<SENT sid="2" pm="."><plain>Mean±SD age was 56±10 </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma <z:chebi fb="0" ids="17933">25-hydroxyvitamin D3</z:chebi> levels were determined by high-performance liquid chromatography/tandem mass spectrometry on baseline samples </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0100512'>Vitamin D deficiency</z:hpo> was defined as a 25-OHD level of less than 20ng/ml </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="27" ids="27300">Vitamin D</z:chebi> levels between 20 and 30ng/ml are termed 'insufficient' </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="27" ids="27300">Vitamin D</z:chebi> levels greater than 30ng/ml are termed 'optimal' </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: 125 patients have <z:hpo ids='HP_0100512'>vitamin D deficiency</z:hpo>, 14 patients have insufficient and the others have optimal </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="27" ids="27300">Vitamin D</z:chebi> levels were not associated with sex, age, BMI, <z:chebi fb="17" ids="39025">HDL</z:chebi>, <z:chebi fb="15" ids="39026">LDL</z:chebi>, <z:chebi fb="0" ids="16737">kreatinin</z:chebi>, <z:hpo ids='HP_0000822'>hypertension</z:hpo> and smoking </plain></SENT>
<SENT sid="9" pm="."><plain>But <z:hpo ids='HP_0100512'>vitamin D deficiency</z:hpo> patients had more longer duration (p=0.011), more higher <z:chebi fb="3" ids="27226">uric acid</z:chebi> (p=0.021), fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> (p=0.037), postprandial <z:chebi fb="105" ids="17234">glucose</z:chebi> (p=0.001) and HbA1c (p=0.026) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: In our study type 2 diabetic patients have 73% of <z:hpo ids='HP_0100512'>vitamin D deficiency</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0100512'>Vitamin D deficiency</z:hpo> predicts higher fasting and postprandial blood <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:mp ids='MP_0002055'>diabetes</z:mp> disregulation </plain></SENT>
<SENT sid="12" pm="."><plain>Type 2 DM patients and low 25-OH <z:chebi fb="27" ids="27300">vitamin D</z:chebi> levels could increased <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> directly or indirectly (low <z:chebi fb="17" ids="39025">HDL</z:chebi> and high <z:chebi fb="3" ids="27226">uric acid</z:chebi> in 25-OH <z:chebi fb="27" ids="27300">vitamin D</z:chebi> &lt;20ng/ml) </plain></SENT>
<SENT sid="13" pm="."><plain>Whether <z:chebi fb="27" ids="27300">vitamin D</z:chebi> substitution improves prognosis remains to be investigated </plain></SENT>
</text></document>